Filing Details
- Accession Number:
- 0001127602-16-047331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-23 17:39:08
- Reporting Period:
- 2016-03-22
- Filing Date:
- 2016-03-23
- Accepted Time:
- 2016-03-23 17:39:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-22 | 10,000 | $36.30 | 498,061 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-03-22 | 6,237 | $153.75 | 491,824 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-03-22 | 3,763 | $154.89 | 488,061 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2016-03-22 | 10,000 | $0.00 | 10,000 | $36.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
145,000 | 2010-02-28 | 2020-01-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,000 | Indirect | By Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 6,237 shares sold ranging from $153.40 to $154.39 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,763 shares sold ranging from $154.50 to $155.20 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.